ArticleOncotarget2017

The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approaches.

Hong-Lian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.